Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy: a prospective observational study

Recipients of chimeric antigen receptor-modified T (CAR-T) cell therapies for B cell malignancies have profound and prolonged immunodeficiencies and are at risk for serious infections, including respiratory virus infections. Vaccination may be important for infection prevention, but there are limite...

Descripción completa

Detalles Bibliográficos
Autores principales: Walti, Carla S, Loes, Andrea N, Shuey, Kiel, Krantz, Elizabeth M, Boonyaratanakornkit, Jim, Keane-Candib, Jacob, Loeffelholz, Tillie, Wolf, Caitlin R, Taylor, Justin J, Gardner, Rebecca A, Green, Damian J, Cowan, Andrew J, Maloney, David G, Turtle, Cameron J, Pergam, Steven A, Chu, Helen Y, Bloom, Jesse D, Hill, Joshua A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549667/
https://www.ncbi.nlm.nih.gov/pubmed/34702753
http://dx.doi.org/10.1136/jitc-2021-003428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549667/
https://www.ncbi.nlm.nih.gov/pubmed/34702753
http://dx.doi.org/10.1136/jitc-2021-003428

Ejemplares similares